We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Accutane Program Needs Changes, Advisory Committees Say
Accutane Program Needs Changes, Advisory Committees Say
August 3, 2007
Members of the Dermatologic and Ophthalmic Drugs and the Drug Safety and Risk Management advisory committees unanimously agreed that iPledge, the risk management program for isotretinoin, needs changes to increase flexibility and reduce treatment interruptions.